Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tanabe

Showing results (671-680 of 759) with videos related to

Pageof 76
Sort By:
Nature Medicine|June 3, 2000
A principal target of human immunity to malaria identified by molecular population genetic and immunological analysesD J Conway, D R Cavanagh, K Tanabe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug CombinationsAdam A Friedman, Yun Xia, Lorenzo Trippa, et al.
Transplantation Proceedings|May 29, 2016
Preemptive Living Donor Kidney Transplantation and Kidney Function at the Initial Hospital Visit: A Single-Center Case-Control StudyJ Hasegawa, H Shirakawa, Y Imaizumi, et al.
Transplantation|February 11, 1998
Long-term results of ABO-incompatible living kidney transplantation: a single-center experienceK Tanabe, K Takahashi, K Sonda, et al.
Japanese Circulation Journal|January 29, 2000
Purulent pericarditis due to group B streptococcus and mycotic aneurysm of the ascending aorta: case reportY Akashi, Y Ikehara, A Yamamoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2015
Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05)K Tanabe, M Fujii, K Nishikawa, et al.
JAMA|January 3, 2008
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosisKenneth K Tanabe, Antoinette Lemoine, Dianne M Finkelstein, et al.
Gastro Hep Advances|August 12, 2024
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention StrategyKenneth K Tanabe, David Zahrieh, Carrie A Strand, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Precision-Cut Liver Slices as an <i>ex vivo</i> model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Hepatology Communications|October 24, 2024
Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Pageof 76

Showing results (671-680 of 759) with videos related to

Sort By:
Pageof 76
Nature Medicine|June 3, 2000
A principal target of human immunity to malaria identified by molecular population genetic and immunological analysesD J Conway, D R Cavanagh, K Tanabe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug CombinationsAdam A Friedman, Yun Xia, Lorenzo Trippa, et al.
Transplantation Proceedings|May 29, 2016
Preemptive Living Donor Kidney Transplantation and Kidney Function at the Initial Hospital Visit: A Single-Center Case-Control StudyJ Hasegawa, H Shirakawa, Y Imaizumi, et al.
Transplantation|February 11, 1998
Long-term results of ABO-incompatible living kidney transplantation: a single-center experienceK Tanabe, K Takahashi, K Sonda, et al.
Japanese Circulation Journal|January 29, 2000
Purulent pericarditis due to group B streptococcus and mycotic aneurysm of the ascending aorta: case reportY Akashi, Y Ikehara, A Yamamoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2015
Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05)K Tanabe, M Fujii, K Nishikawa, et al.
JAMA|January 3, 2008
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosisKenneth K Tanabe, Antoinette Lemoine, Dianne M Finkelstein, et al.
Gastro Hep Advances|August 12, 2024
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention StrategyKenneth K Tanabe, David Zahrieh, Carrie A Strand, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Precision-Cut Liver Slices as an <i>ex vivo</i> model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Hepatology Communications|October 24, 2024
Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Pageof 76